Wolverine Trading, LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $52,078 - $67,418	1,300 Added 6.5%	21,300 $853,000
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $32,805 - $42,930	900 Added 4.71%	20,000 $953,000
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $222,759 - $283,815	5,300 Added 38.41%	19,100 $827,000
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $390,510 - $464,670	9,000 Added 187.5%	13,800 $698,000
Q3 2023 Nov 15, 2023	BUY	$38.5 - $47.13 $184,800 - $226,224	4,800 New	4,800 $217,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $92,196 - $126,360	3,600 Added 3.36%	110,800 $3.38 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $127,452 - $154,090	-3,800 Reduced 3.42%	107,200 $3.6 Million
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $283,228 - $387,450	-8,200 Reduced 6.88%	111,000 $4.39 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $3.9 Million - $5.86 Million	91,800 Added 335.04%	119,200 $5.33 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $8.24 Million - $11 Million	-181,900 Reduced 86.91%	27,400 $1.57 Million
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $4.81 Million - $6.38 Million	101,400 Added 93.98%	209,300 $10.1 Million
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $257,675 - $335,775	-5,500 Reduced 4.85%	107,900 $6.41 Million
Q1 2020 May 11, 2020	SELL	$41.6 - $63.4 $2.66 Million - $4.06 Million	-64,000 Reduced 36.08%	113,400 $5.47 Million
Q4 2019 Feb 12, 2020	SELL	$53.85 - $65.27 $1.79 Million - $2.17 Million	-33,200 Reduced 15.76%	177,400 $10.7 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $5.28 Million - $6.45 Million	89,400 Added 73.76%	210,600 $12.4 Million
Q2 2019 Aug 20, 2019	SELL	$62.09 - $86.14 $1.07 Million - $1.49 Million	-17,300 Reduced 12.49%	121,200 $7.79 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $428,652 - $657,477	8,100 Added 6.21%	138,500 $11.2 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $333,949 - $458,458	-7,700 Reduced 5.58%	130,400 $6.7 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $3.11 Million - $3.9 Million	72,600 Added 110.84%	138,100 $7.12 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $489,288 - $611,055	11,100 Added 20.4%	65,500 $2.89 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $211,260 - $270,438	-4,200 Reduced 7.17%	54,400 $2.74 Million
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $2.67 Million - $3.49 Million	58,600	58,600 $2.97 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$543 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$511 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$372 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$315 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$284 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.12B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account